Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Companies
  4. /
  5. Biovectra Inc., Canada – FDA Inspections
Company
•Canada

Biovectra Inc., Canada – FDA Inspections

Inspection records and compliance data for Biovectra Inc.. 1 FDA inspection on record, 1 Form 483, last inspected September 12, 2024.

Sign in to open in Dashboard
Company Profile

This profile covers Biovectra Inc. based in Canada.

FDA Inspection History

FDA inspections
1
OAI
0
VAI
0
NAI
0
Unclassified
1
Form 483s
1
Warning letters
0

Inspected September 12, 2024.

FDA inspections (1)

DateResultFDA center(s)Insp. #
September 12, 2024Not classifiedHuman Drugs1261629
FDA documents

Form 483s (1)

  • Form 483s · September 12, 2024
People (2)
Farzaneh Dellilbavi-Ragheb
Person
Esther C. Broner
Person
Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Auroactive Pharma Private Limited
MABXIENCE S.A.U.
Shionogi Pharma Co. Ltd.
R. Mason (Chemicals), Ltd.
Apitoria Pharma Private Limited
Evive Biopharmaceutical (Beijing), Ltd.
Shandong Anshun Pharmaceutical Co., Ltd.
Patheon Biologics LLC
MacroGenics, Inc
Binex Co., Ltd
Company Information

Name

Biovectra Inc.

FEI Number

3015684350

Address

Canada

Country

Canada

ID: 46cb104d-9e11-4208-8344-cc8186412a02

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.